Saba Capital Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,513
Closed -$372K – 469
2026
Q2
$283K Buy
1,513
+14
+0.9% +$2.57K 0.01% 260
2026
Q1
$283K Buy
+1,499
New +$316K 0.01% 253
2018
Q2
– Sell
-613,605
Closed -$14.9M – 123
2018
Q1
$14.9M Sell
613,605
-484,316
-44% -$9.6M 0.83% 29
2017
Q4
$16.6M Buy
1,097,921
+71,945
+7% +$1.01M 1.3% 20
2017
Q3
$16.9M Buy
1,025,976
+215,714
+27% +$3.66M 1.71% 20
2017
Q2
$15.7M Buy
810,262
+315,880
+64% +$5.51M 1.42% 21
2017
Q1
$8.76M Buy
494,382
+321,287
+186% +$5.96M 0.78% 33
2016
Q4
$2.57M Buy
173,095
+119,605
+224% +$2.15M 0.26% 53
2016
Q3
$1.21M Buy
+53,490
New +$1.39M 0.12% 60
2014
Q4
– Sell
-10,000
Closed -$594K – 178
2014
Q3
$594K Sell
10,000
-38,378
-79% -$2.14M 0.03% 164
2014
Q2
$2.27M Sell
48,378
-78,770
-62% -$3.56M 0.12% 116
2014
Q1
$5.44M Buy
127,148
+29,700
+30% +$1.31M 0.31% 74
2013
Q4
$4.1M Sell
97,448
-61,893
-39% -$2.69M 0.24% 92
2013
Q3
$6.56M Buy
159,341
+65,241
+69% +$2.73M 0.55% 50
2013
Q2
$4.34M Buy
+94,100
New +$4.21M 0.54% 43

Other funds holding THC

Saba Capital Management's THC Position: Q3 2026 in Review

Saba Capital Management sold out of Tenet Healthcare (THC) in Q3 2026, closing a stake of 1,513 shares — an estimated $372K sold.

Saba Capital Management first reported a position in THC in Q2 2013 and held it in 15 quarters. The position peaked at $16.9M in Q3 2017. 782 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Saba Capital Management reported no remaining Tenet Healthcare position as of Q3 2026 after selling out during the quarter.
  • Saba Capital Management sold 1,513 Tenet Healthcare shares in Q3 2026, an estimated $372K.
  • Saba Capital Management first reported a position in Tenet Healthcare in Q2 2013 and held it in 15 quarters.
  • Saba Capital Management's Tenet Healthcare position peaked at $16.9M in Q3 2017.
  • 782 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Saba Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.